Has Nicholas Shaheen, MD received payments from drug or device companies?

Yes. Drug and device makers reported $144,993 in general payments to Nicholas Shaheen, MD across 76 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nicholas Shaheen, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nicholas Shaheen, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nicholas Shaheen, MD

Gastroenterology · Chapel Hill, NCNPI 1467521757

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $133,235 of the $144,993 with a category attached, or 91.9%. 14 manufacturers reported payments, led by Lucid Diagnostics Inc. at 45.6% of the total. Reporting peaked in 2021 at $79,667 and has fallen 89.7% since, to $8,193 in 2025. Among gastroenterology clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$144,993in general payments, 2019–2025

Across 76 payments — averaging $1907.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lucid Diagnostics Inc.$66K
Phathom Pharmaceuticals, Inc.$24K
Intercept Pharmaceuticals, Inc.$18K
Wilson Cook Medical Incorporated$12K
Takeda Pharmaceuticals U.S.A., Inc.$9K
US Endoscopy$6K
plus $10K from 8 others

$1,372,576in research payments, 2019–2025

Across 82 payments — averaging $16,739 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pentax Of America, Inc.$1.2M
Lucid Diagnostics Inc.$100K
Merit Medical Systems Inc$48K
Ironwood Pharmaceuticals, Inc$47K
Covidien LP$10K
US Endoscopy$4K

What the payments were for

Consulting fees$133,23592%
Speaking & faculty fees$8,7506%
Travel & lodging$1,1201%
Food & beverage$1,8871%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lucid Diagnostics Inc.	7	$66,143
Phathom Pharmaceuticals, Inc.	25	$24,217
Intercept Pharmaceuticals, Inc.	3	$17,850
Wilson Cook Medical Incorporated	10	$12,257
Takeda Pharmaceuticals U.S.A., Inc.	1	$9,425
US Endoscopy	4	$5,500
Pentax Of America, Inc.	3	$3,072
CSA Medical, Inc	2	$2,249
Exact Sciences	4	$1,855
Medtronic	3	$1,565
Steris Corporation	3	$393
Covidien LP	2	$298
AbbVie	8	$137
Regeneron Healthcare Solutions, Inc.	1	$32

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$144,993 in reported general payments places this provider in the 95th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina →

Medicare billing

Part B allowed, 2024

$46,778

Medicare patients

206

Services billed

362

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sucralfate	21	$6,075
Omeprazole	182	$3,745
Esomeprazole Magnesium	65	$3,684
Pantoprazole Sodium	139	$2,441
Amitriptyline Hcl	35	$669
Lansoprazole	11	$326
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	13	$53

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Chapel Hill

Paul WatkinsChapel Hill$876K
Evan DellonChapel Hill$431K
Alfred BarrittChapel Hill$210K
Christine HuntChapel Hill$122K
Hans HerfarthChapel Hill$78K
Simon GrayChapel Hill$48K
Jasmine BarrowChapel Hill$22K
Stephen DealCharlotte$945K
Fred FowlerCharlotte$932K
Nilesh LodhiaCharlotte$735K

See the full list for North Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →